Geron (GERN)
(Delayed Data from NSDQ)
$4.29 USD
-0.33 (-7.14%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $4.28 -0.01 (-0.23%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Brokerage Reports
Geron Corporation [GERN]
Reports for Purchase
Showing records 1 - 20 ( 243 total )
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Ready to Rumble; Capitalizing on Robust Opportunity for Rytelo
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
RYTELO (imetelstat) Approved; Label Looks Best-Case
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
We?re Not Surprised; AdCom Votes in Favor of Imetelstat
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Briefing Docs In-Line with Expectations; Remain Confident in Imetelstat
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
ASH 2023 Day 3 Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Q3 Financials; Buckle Up for an Action-Packed 2024
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
COMMANDS to Frontline; Luspatercept Approved for 1L LRMDS
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R